Leukemia

OGT Launches New Panel for Myeloid Cancer

OGT launched a new next-generation sequencing (NGS) tool designed to identify key fusion genes associated with acute myeloid leukemia (AML).

Leukemia

Faster Genomics-Based Diagnosis May Accelerate Treatment of Myeloid Neoplasms Patients

Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.

Leukemia

Acute Myeloid Leukemia Subtypes Help Treatment

To better treat patients with acute myeloid leukemia, researchers discovered a novel subtype of the cancer via proteome and genetic analysis.

Interventional Study to Evaluate Multicancer Early Detection Test

Apr 21, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types

The Pathfinder study will enroll 6,200 participants to evaluate Grail’s investigational multicancer early detection test in clinical practice.

OGT Updates SureSeq NGS Portfolio

Apr 10, 2020 | Cancer, Leukemia, Molecular Diagnostics

The latest update is beneficial to researchers investigating myeloid disorders, and is now enabled with BCR-ABL fusion gene and KMT2A-PTD detection.

Study Offers Promise for Multicancer Detection from a Single Blood Draw

Apr 6, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types

Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.

OGT Releases NGS Panel for Somatic CNV Detection in Chronic Lymphocytic Leukemia

Mar 16, 2020 | Cancer, Leukemia, Microarray Systems, Molecular Diagnostics

The panel has been tested to show excellent concordance with array data, and can detect both small and large CNVs, indels, LOH, and SNVs.

FDA Clears Analyzer for Fingerstick Blood Testing

Jan 9, 2020 | Leukemia

Sight Diagnostics’ patented Olo analyzer digitizes blood into images to perform the most common blood test in minutes, using just two drops of blood.

NGS Detects Bloodstream Infections in Pediatric Cancer Patients before Symptoms Develop

Dec 31, 2019 | Cardiovascular, Leukemia

The Karius test detected bloodstream infections in 75% of cases as early as 3 days before pediatric leukemia patients became symptomatic.

Elevating Pathology

Oct 8, 2019 | Culture Media, Cytology, Histology, Leukemia, Lymphoma, Microscopy, Slides, Software

AI-driven digital pathology can accelerate cancer diagnosis and clinical trial recruitment.

Preliminary Data Confirm Saphyr’s Potential to Replace Traditional Cytogenetics Methods for Detecting Structural Variants in Certain Blood Cancers

Sep 17, 2019 | Leukemia, Microarray Systems

Strong concordance with standard-of-care methods shows how the Saphyr mapping system can transform cytogenetic workflows and improve blood cancer treatment.

Liquid Biopsies Guide Improved Cancer Treatment

Aug 26, 2019 | Breast, Cytology, Histology, Leukemia, Lung Cancer, Melanoma, Molecular Diagnostics, Prostate

Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.

Saga Raises $4.1 Million to Advance Ultrasensitive Liquid Biopsies

Aug 7, 2019 | Breast, Leukemia, Lung Cancer, Molecular Diagnostics

The funds will be used to accelerate commercialization of Saga’s portfolio of kits and services, continue development of new products, and perform prospective clinical studies.

Cytek Biosciences Debuts Advanced Five-Laser Flow Cytometer

Aug 7, 2019 | Filters, Flow Cytometry, Flow Cytometry Instruments, Leukemia, Lymphoma

The Aurora system is now available with five lasers, making it possible for researchers to visualize more than 30 colors from a single sample.

Single-Cell Genomics Study Reveals Clonal Diversity Underlying Resistance to Leukemia Therapy

Jul 8, 2019 | Leukemia

The study demonstrates the potential for more impactful, dynamic therapy development and applications for those with acute myeloid leukemia.

Canopy Biosciences Licenses Technology for Error-Corrected Sequencing

Mar 14, 2019 | Cardiovascular, Leukemia

The license encompasses both a novel method and bioinformatic tools that combine to improve the level of detection in NGS, allowing for the identification of ultrarare gene variants.